USPRX
Price
$90.73
Change
+$0.62 (+0.69%)
Updated
Jul 31 closing price
Net Assets
15.33B
VTSAX
Price
$179.26
Change
+$1.02 (+0.57%)
Updated
Jul 31 closing price
Net Assets
2.3T
Interact to see
Advertisement

USPRX vs VTSAX

USPRX vs VTSAX Comparison Chart in %
View a ticker or compare two or three
VS
USPRX vs. VTSAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is USPRX is a StrongBuy and VTSAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VTSAX has more cash in the bank: 2.3T vs. USPRX (15.3B). VTSAX pays higher dividends than USPRX: VTSAX (1.05) vs USPRX (0.88). USPRX was incepted earlier than VTSAX: USPRX (24 years) vs VTSAX (26 years). USPRX (0.19) is less costly to investors than VTSAX (0.04). VTSAX is a more actively managed with annual turnover of: 3.00 vs. USPRX (2.00). VTSAX has a lower initial minimum investment than USPRX: VTSAX (3000) vs USPRX (100000). VTSAX annual gain was more profitable for investors over the last year : 18.52 vs. USPRX (15.52). VTSAX (63.13) and USPRX (60.73) have equivalent 5 years return.
USPRXVTSAXUSPRX / VTSAX
Total Expense Ratio0.150.04375%
Annual Report Gross Expense Ratio0.190.04475%
Fund Existence24 years26 years-
Gain YTD10.1349.883103%
Front LoadN/AN/A-
Min. Initial Investment10000030003,333%
Min. Initial Investment IRAN/AN/A-
Net Assets15.3B2.3T1%
Annual Yield % from dividends0.881.0584%
Returns for 1 year15.5218.5284%
Returns for 3 years60.0562.1897%
Returns for 5 years60.7363.1396%
Returns for 10 years226.25246.7692%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DQICX39.590.21
+0.53%
BNY Mellon Equity Income Fund C
CLREX57.720.27
+0.47%
Columbia Balanced Inst2
DBORX25.450.10
+0.39%
BNY Mellon Balanced Opportunity I
DRRYX17.750.02
+0.11%
BNY Mellon Global Real Return - Y
LYFIX17.94-0.50
-2.71%
AlphaCentric Life Sciences & Hlthcare I